EE351 Economic Evaluation of Botulinum Toxin Type a (XEOMEEN) in the Treatment of Adult Patients With Spasticity in the "IMSS” and “ISSSTE”
Abstract
Authors
Rosal y Hermosillo A Del Hevia J Agramonte Lopez S Vergara Molina H Soto Gasga AE Frias Paz EJ Palomo L.J. Peralta-Hernández Martínez F Gómez